As of 2026-04-01, the Fair Value of Second Sight Medical Products Inc (EYES) is -6.79 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.14 USD, the upside of Second Sight Medical Products Inc is -264.13%.
With the market price of 4.14 USD and our fair value calculation, Second Sight Medical Products Inc (EYES) is not a good investment. Investing in EYES stocks now will result in a potential loss of 264.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | - | - | 5Y Avg | |
| Net income | -14.88 | -8.92 | - | - | -11.90 | |
| YoY growth | 55.70% | 40.05% | - | - | 47.88% | |
| Market Cap (mil) | 54.38 |
| P/E | |
| Forward P/E |
| EPS | -0.27 |
| Avg earnings growth rate | 47.88% |
| TTM earnings | -8.92 |